Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (221-230 of 421) with videos related to

Pageof 43
Sort By:
Scientific Reports|June 26, 2013
Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas casesBo Zhang, Jin Xu, Chen Liu, et al.
Biomarker Research|February 4, 2026
Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potentialYijia Chen, Hanzhe Shi, Mingming Xiao, et al.
Acta Biochimica Et Biophysica Sinica|September 5, 2025
The ACSS2-PPARD-BCAT1 axis synchronously regulates branched-chain amino acid metabolism and development in pancreatic cancerHaidi Chen, Zeng Ye, Lijun Liu, et al.
International Journal of Molecular Sciences|October 23, 2021
Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic CancerJianhui Yang, Jin Xu, Bo Zhang, et al.
Computational and Structural Biotechnology Journal|August 11, 2022
Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancerSiyuan Lu, Jie Hua, Jin Xu, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Cuproptosis-Related Gene <i>DLAT</i> as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics AnalysisZengli Fang, Wei Wang, Yuan Liu, et al.
International Journal of Oncology|April 23, 2020
Lewis antigen‑negative pancreatic cancer: An aggressive subgroupChen Liu, Shengming Deng, Kaizhou Jin, et al.
Frontiers in Oncology|April 29, 2021
Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal AdenocarcinomaRong Tang, Xiaomeng Liu, Wei Wang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2015
Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancerZuqiang Liu, Guopei Luo, Meng Guo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 10, 2020
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant ChemotherapyChen Liu, He Cheng, Kaizhou Jin, et al.
Pageof 43

Showing results (221-230 of 421) with videos related to

Sort By:
Pageof 43
Scientific Reports|June 26, 2013
Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas casesBo Zhang, Jin Xu, Chen Liu, et al.
Biomarker Research|February 4, 2026
Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potentialYijia Chen, Hanzhe Shi, Mingming Xiao, et al.
Acta Biochimica Et Biophysica Sinica|September 5, 2025
The ACSS2-PPARD-BCAT1 axis synchronously regulates branched-chain amino acid metabolism and development in pancreatic cancerHaidi Chen, Zeng Ye, Lijun Liu, et al.
International Journal of Molecular Sciences|October 23, 2021
Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic CancerJianhui Yang, Jin Xu, Bo Zhang, et al.
Computational and Structural Biotechnology Journal|August 11, 2022
Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancerSiyuan Lu, Jie Hua, Jin Xu, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Cuproptosis-Related Gene <i>DLAT</i> as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics AnalysisZengli Fang, Wei Wang, Yuan Liu, et al.
International Journal of Oncology|April 23, 2020
Lewis antigen‑negative pancreatic cancer: An aggressive subgroupChen Liu, Shengming Deng, Kaizhou Jin, et al.
Frontiers in Oncology|April 29, 2021
Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal AdenocarcinomaRong Tang, Xiaomeng Liu, Wei Wang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2015
Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancerZuqiang Liu, Guopei Luo, Meng Guo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 10, 2020
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant ChemotherapyChen Liu, He Cheng, Kaizhou Jin, et al.
Pageof 43